Systemic diseases and the cornea

R Shah, C Amador, K Tormanen, S Ghiam… - Experimental eye …, 2021 - Elsevier
There is a number of systemic diseases affecting the cornea. These include endocrine
disorders (diabetes, Graves' disease, Addison's disease, hyperparathyroidism), infections …

HTLV-1, the other pathogenic yet neglected human retrovirus: from transmission to therapeutic treatment

N Futsch, R Mahieux, H Dutartre - Viruses, 2017 - mdpi.com
Going back to their discovery in the early 1980s, both the Human T-cell Leukemia virus type-
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …

Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein

E Jaworski, A Narayanan, R Van Duyne… - Journal of Biological …, 2014 - ASBMB
Human T-lymphotropic virus type 1 (HTLV-1) is the causative agent of adult T-cell leukemia
and HTLV-1-associated myelopathy/tropical spastic paraparesis. The HTLV-1 transactivator …

Immunological homeostasis of the eye

M Mochizuki, S Sugita, K Kamoi - Progress in retinal and eye research, 2013 - Elsevier
Uveitis is a sight-threatening disease caused by autoimmune or infection-related immune
responses. Studies in experimental autoimmune uveitis and in human diseases imply that …

Virus-driven carcinogenesis

Y Hatano, T Ideta, A Hirata, K Hatano, H Tomita… - Cancers, 2021 - mdpi.com
Simple Summary Carcinogens, causes of cancer, are usually invisible and therefore in vivo
carcinogenesis is difficult to detect. Tumor viruses, definitive carcinogens, are also usually …

[HTML][HTML] 40 years of the human T-cell leukemia virus: past, present, and future

Y Tagaya, M Matsuoka, R Gallo - F1000Research, 2019 - ncbi.nlm.nih.gov
It has been nearly 40 years since human T-cell leukemia virus-1 (HTLV-1), the first
oncogenic retrovirus in humans and the first demonstrable cause of cancer by an infectious …

Ocular inflammation post-vaccination

Y Zou, K Kamoi, Y Zong, J Zhang, M Yang… - Vaccines, 2023 - mdpi.com
The association between vaccines and ocular disorders has attracted significant attention in
scientific research. Numerous mainstream vaccines are associated with a range of uveitis …

Updates on HTLV-1 uveitis

K Kamoi, T Watanabe, K Uchimaru, A Okayama, S Kato… - Viruses, 2022 - mdpi.com
HTLV-1 uveitis (HU) is the third clinical entity to be designated as an HTLV-1-associated
disease. Although HU is considered to be the second-most frequent HTLV-1-associated …

Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL

M Kannagi, A Hasegawa, Y Nagano, S Kimpara… - Retrovirology, 2019 - Springer
Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL),
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and other …

Inhibition of tunneling nanotube (TNT) formation and human T-cell leukemia virus type 1 (HTLV-1) transmission by cytarabine

M Omsland, C Pise-Masison, D Fujikawa, V Galli… - Scientific Reports, 2018 - nature.com
The human T-cell leukemia virus type 1 (HTLV-1) is highly dependent on cell-to-cell
interaction for transmission and productive infection. Cell-to-cell interactions through the …